BiomX Inc.
PHGE
$0.52
-$0.03-5.47%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.37% | -20.60% | 25.13% | 46.54% | 55.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.36% | -13.03% | 5.34% | 22.30% | 47.96% |
| Operating Income | 34.36% | 13.03% | -5.34% | -22.30% | -47.96% |
| Income Before Tax | -492.22% | -104.31% | -329.79% | 29.25% | 78.31% |
| Income Tax Expenses | -33.33% | -46.15% | -18.18% | -68.42% | -59.09% |
| Earnings from Continuing Operations | -491.64% | -104.20% | -329.35% | 29.28% | 78.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -491.64% | -104.20% | -329.35% | 29.28% | 78.30% |
| EBIT | 34.36% | 13.03% | -5.34% | -22.30% | -47.96% |
| EBITDA | 40.64% | 17.04% | -0.27% | -20.28% | -45.86% |
| EPS Basic | -1,128.98% | 33.90% | 29.66% | 77.11% | 102.10% |
| Normalized Basic EPS | -320.50% | 52.79% | 59.38% | 97.53% | 107.29% |
| EPS Diluted | 51.57% | 73.55% | 67.22% | 85.36% | 55.42% |
| Normalized Diluted EPS | -482.96% | 57.09% | 62.17% | 97.63% | 104.20% |
| Average Basic Shares Outstanding | 114.58% | 133.11% | 203.83% | 267.44% | 197.58% |
| Average Diluted Shares Outstanding | 93.01% | 103.19% | 149.48% | 181.44% | 230.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |